137 related articles for article (PubMed ID: 31465967)
1. Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase.
Yang KY; Wu CR; Zheng MZ; Tang RT; Li XZ; Chen LX; Li H
Bioorg Chem; 2019 Nov; 92():103186. PubMed ID: 31465967
[TBL] [Abstract][Full Text] [Related]
2. Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor.
Cheng L; Wu CR; Zhu LH; Li H; Chen LX
Bioorg Med Chem Lett; 2017 Mar; 27(5):1243-1246. PubMed ID: 28174105
[TBL] [Abstract][Full Text] [Related]
3. A natural inhibitor of kidney-type glutaminase: a withanolide from
Wu C; Zheng M; Gao S; Luan S; Cheng L; Wang L; Li J; Chen L; Li H
Oncotarget; 2017 Dec; 8(69):113516-113530. PubMed ID: 29371926
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M
Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.
Thangavelu K; Pan CQ; Karlberg T; Balaji G; Uttamchandani M; Suresh V; Schüler H; Low BC; Sivaraman J
Proc Natl Acad Sci U S A; 2012 May; 109(20):7705-10. PubMed ID: 22538822
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.
Huang Q; Stalnecker C; Zhang C; McDermott LA; Iyer P; O'Neill J; Reimer S; Cerione RA; Katt WP
J Biol Chem; 2018 Mar; 293(10):3535-3545. PubMed ID: 29317493
[TBL] [Abstract][Full Text] [Related]
7. Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity.
Chen Z; Li D; Xu N; Fang J; Yu Y; Hou W; Ruan H; Zhu P; Ma R; Lu S; Cao D; Wu R; Ni M; Zhang W; Su W; Ruan BH
J Med Chem; 2019 Jan; 62(2):589-603. PubMed ID: 30543285
[TBL] [Abstract][Full Text] [Related]
8. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
Masamha CP; LaFontaine P
J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA).
Thangavelu K; Chong QY; Low BC; Sivaraman J
Sci Rep; 2014 Jan; 4():3827. PubMed ID: 24451979
[TBL] [Abstract][Full Text] [Related]
10. Biomolecular Interaction Assays Identified Dual Inhibitors of Glutaminase and Glutamate Dehydrogenase That Disrupt Mitochondrial Function and Prevent Growth of Cancer Cells.
Zhu M; Fang J; Zhang J; Zhang Z; Xie J; Yu Y; Ruan JJ; Chen Z; Hou W; Yang G; Su W; Ruan BH
Anal Chem; 2017 Feb; 89(3):1689-1696. PubMed ID: 28208301
[TBL] [Abstract][Full Text] [Related]
11. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism.
Sun W; Luan S; Qi C; Tong Q; Yan S; Li H; Zhang Y
Cell Commun Signal; 2019 Aug; 17(1):111. PubMed ID: 31470862
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for exploring the allosteric inhibition of human kidney type glutaminase.
Ramachandran S; Pan CQ; Zimmermann SC; Duvall B; Tsukamoto T; Low BC; Sivaraman J
Oncotarget; 2016 Sep; 7(36):57943-57954. PubMed ID: 27462863
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.
Gross MI; Demo SD; Dennison JB; Chen L; Chernov-Rogan T; Goyal B; Janes JR; Laidig GJ; Lewis ER; Li J; Mackinnon AL; Parlati F; Rodriguez ML; Shwonek PJ; Sjogren EB; Stanton TF; Wang T; Yang J; Zhao F; Bennett MK
Mol Cancer Ther; 2014 Apr; 13(4):890-901. PubMed ID: 24523301
[TBL] [Abstract][Full Text] [Related]
14. Physapubescin B Exhibits Potent Activity against Human Prostate Cancer In Vitro and In Vivo.
Ding W; Hu Z; Zhang Z; Ma Q; Tang H; Ma Z
J Agric Food Chem; 2015 Nov; 63(43):9504-12. PubMed ID: 26415552
[TBL] [Abstract][Full Text] [Related]
15. BPTES inhibition of hGA(124-551), a truncated form of human kidney-type glutaminase.
Hartwick EW; Curthoys NP
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):861-7. PubMed ID: 21999665
[TBL] [Abstract][Full Text] [Related]
16. Ebselen: Mechanisms of Glutamate Dehydrogenase and Glutaminase Enzyme Inhibition.
Yu Y; Jin Y; Zhou J; Ruan H; Zhao H; Lu S; Zhang Y; Li D; Ji X; Ruan BH
ACS Chem Biol; 2017 Dec; 12(12):3003-3011. PubMed ID: 29072450
[TBL] [Abstract][Full Text] [Related]
17. Induction of quinone reductase (QR) by withanolides isolated from Physalis pubescens L. (Solanaceae).
Ji L; Yuan Y; Ma Z; Chen Z; Gan L; Ma X; Huang D
Steroids; 2013 Sep; 78(9):860-5. PubMed ID: 23685089
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors.
Yeh TK; Kuo CC; Lee YZ; Ke YY; Chu KF; Hsu HY; Chang HY; Liu YW; Song JS; Yang CW; Lin LM; Sun M; Wu SH; Kuo PC; Shih C; Chen CT; Tsou LK; Lee SJ
J Med Chem; 2017 Jul; 60(13):5599-5612. PubMed ID: 28609101
[TBL] [Abstract][Full Text] [Related]
19. Caudatan A, an undescribed human kidney-type glutaminase inhibitor with tetracyclic flavan from Ohwia caudata.
Sun Y; Feng X; Liu X; Qian C; Che X; Cao F; Jin S; Meng D
Phytochemistry; 2018 Aug; 152():22-28. PubMed ID: 29715600
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel tellurodibenzoic acid compounds as kidney-type glutaminase (KGA) inhibitors.
Hou W; Zhou Y; Rui J; Bai R; Bhasin AKK; Ruan BH
Bioorg Med Chem Lett; 2019 Jul; 29(13):1673-1676. PubMed ID: 31076348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
